Clozapine is an atypical antipsychotic drug indicated for the management of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. It has demonstrated superior efficacy in treating both the positive and negative symptoms in treatment-refractory cases.
It also has the added benefit of causing minimal extrapyramidal sideeffects, producing no tardive dyskinesia and having little effect on prolactin levels. 2 Although clozapine has a number of side-effects (Table I) clinical focus falls mainly on the serious adverse effects of agranulocytosis (0.38 -1%) and seizures (1 -6%). 2 However, constipation is a much more common side-effect occurring in 14 -60% of patients, 3,4 with a total of 5 fatalities (all males)
having been described in the literature. [4] [5] [6] [7] [8] In terms of the 5 fatalities significant variations in dosage (400 -750 mg/d) and duration of treatment with clozapine (36 days -6 years) were described. Of these, 2 patients died of aspiration pneumonia (bowel obstruction with faecal vomitus), 2 died secondary to large-bowel necrosis and ischaemia due to faecal impaction, and 1 due to colon perforation with faeculant peritonitis. 
Cases Case 1
A 35-year-old man with a diagnosis of schizophrenia of 6 years' duration and mild intellectual impairment presented with acute abdominal symptoms. He had been started on clozapine 12 days before the onset of his symptoms because of non-response on other antipsychotics. The dosage had been increased by 25 mg every 3 days; at onset of symptoms he was on 150 mg/d. He was also on chlorpromazine, which was being cross-tapered and had been stopped 2 days before symptoms started. There was no previous medical history of note. He presented with acute onset of abdominal cramps, abdominal distension, dyspnoea and drowsiness. On examination he was found to have respiratory distress with wheezing, and a distended and tender abdomen with increased bowel sounds.
Special investigations revealed faecal impaction (abdominal radiograph) and aspiration pneumonia (chest radiograph).
His condition deteriorated and he required intubation and ventilation for 9 days before recovering. He was readmitted Special care was given to an even slower increase in dosage, and attention was paid to proper diet and stool patterns. His psychiatric condition stabilised and he was discharged without lasting sequelae.
Case 2
A 43-year-old man had been diagnosed with disorganised schizophrenia more than 20 years previously and had been on treatment with clozapine for more than 10 years. He had been institutionalised for the past 3 years because of ongoing symptomatology, and in the 4 months before his death the clozapine dosage had been gradually increased from 400 mg to 700 mg/d. The patient was not receiving any concomitant treatment and there was no medical history of note.
He presented with acute onset of food refusal, and a distended, tender abdomen. At the medical facility he was found to have bowel obstruction secondary to faecal impaction and was taken to theatre for a laparotomy, but he had a cardiac arrest during surgery. A postmortem revealed a markedly distended colon filled with large amounts of liquid faeces and air. The entire colon showed ischaemic change that was almost necrotic in some areas.
Case 3
A 23-year-old man had been diagnosed with schizophrenia 
Case 4
A 56-year-old man had been diagnosed with schizophrenia for more than 30 years and had been treated with clozapine See Table II for a summary of case data.
Discussion
Constipation is a common side-effect of a large proportion of psychotropic drugs. The assumption is made that constipation is an anticholinergic side-effect due to gastric motor dysfunction and delayed gastric emptying. 5 In the case of clozapine a contributing factor could be longstanding use of high dosages of other antipsychotic treatment with the accompanying decreased bowel motility, before switching to clozapine.
There seem to be two mechanisms whereby clozapine-induced constipation can be fatal. The first is bowel obstruction leading to distension and necrosis of the bowel, followed by acute abdomen and sepsis. The second is bowel obstruction with inhalation of faeculant material/vomitus. The literature review revealed 5 deaths -2 as a result of aspiration pneumonia and 3 as a result of acute abdomen and sepsis. [4] [5] [6] [7] [8] This correlates
with the findings of our study where 3 patients died as a result of bowel obstruction and 1 as a result of aspiration pneumonia.
Another common element is that the diagnosis is often difficult or delayed. There seem to be two possible explanations for this, the first being altered pain sensitivity, and the second being difficulty in expressing pain. The phenomenon of a possible syndrome of pain insensitivity in patients with schizophrenia has been described. 11 A confounding factor could be the use of neuroleptic and anticonvulsant medication, both with sedative and pain-modulating effects. Patients with schizophrenia may also find it difficult to express their pain. 12 This is especially apparent in patients with marked negative symptoms and severe thought disorder (difficulty in organising thoughts so as to complain or express pain). If a patient is paranoid, especially towards the staff, conveying the symptoms could be problematic.
An additional component of difficulty in expressing pain could be the presence of intellectual impairment. Complaints might not be articulated because of a lack of adequate vocabulary, or requests might not be heard or valued by staff.
It would seem therefore that a number of risk factors are involved in the development of clozapine-induced constipation, especially in chronically ill patients who are institutionalised.
These patients are often on high dosages of antipsychotic treatment, especially clozapine. 4 There is also the possibility of concomitant treatment, with further anticholinergic effects (anticonvulsants, tricyclic antidepressants, and chlorpromazine).
Many patients also remain symptomatic, with severe thought disorder, disorganised behaviour, and paranoid delusions. In conclusion, it is clear that clozapine-induced constipation is common and that it can be fatal if left untreated or There should be an increased awareness among all mental health care providers regarding the risk of constipation in institutionalised patients and the sequelae of this, and also a low threshold for investigating and treating clozapine-induced constipation.
